Tower Research Capital (TRC)’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Tower Research Capital (TRC)’s Portfolio IBDR Stock Details IBDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$90.8K	Sell	3,747 -4,082	-52%	-$98.8K	﹤0.01%	2267
2026 Q1	$190K	Buy	7,829 +5,562	+245%	+$135K	﹤0.01%	1664
2025 Q4	$54.9K	Sell	2,267 -13,485	-86%	-$327K	﹤0.01%	2350
2025 Q3	$383K	Buy	+15,752	New	+$381K	0.01%	1029
2017 Q2	–	Sell	-200	Closed	-$5K	–	3032
2017 Q1	$5K	Buy	+200	New	+$4.79K	﹤0.01%	2198

Other funds holding IBDR

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

GWA

Gratus Wealth Advisors Virginia Beach, Virginia $786M AUM 21.07% 1-Year Est. Return

KCM

Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return

Tower Research Capital (TRC)'s IBDR Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 52% in Q2 2026, selling an estimated $98.8K and leaving 3,747 shares worth $90.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2267.

Tower Research Capital (TRC) first reported a position in IBDR in Q1 2017 and has held it in 5 quarters since. The position peaked at $383K in Q3 2025. 424 funds tracked by Wall St. Rank hold IBDR as of Q2 2026.

Tower Research Capital (TRC) held 3,747 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $90.8K as of Q2 2026.
Tower Research Capital (TRC) sold 4,082 iShares iBonds Dec 2026 Term Corporate ETF shares in Q2 2026, an estimated $98.8K.
iShares iBonds Dec 2026 Term Corporate ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2267 holding.
Tower Research Capital (TRC) first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q1 2017 and has held it in 5 quarters since.
Tower Research Capital (TRC)'s iShares iBonds Dec 2026 Term Corporate ETF position peaked at $383K in Q3 2025.
424 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.